ClinicalTrials.gov
ClinicalTrials.gov Menu

Tolvaptan in Hyponatremic Cancer Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01199198
Recruitment Status : Completed
First Posted : September 10, 2010
Last Update Posted : January 9, 2015
Sponsor:
Collaborator:
Otsuka Pharmaceutical Development & Commercialization, Inc.
Information provided by (Responsible Party):
M.D. Anderson Cancer Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : September 2013
  Actual Study Completion Date : September 2013